E-LIB Suche - Ergebnisse für: To, Kenneth K.W.

1

ABCG2: A perspective:

Robey, Robert W. ; To, Kenneth K.K. ; Polgar, Orsolya...
Advanced Drug Delivery Reviews. 61 (2009) 1 - p. 3-13 , 2009

Link: https://doi.org/10.1016/..

2

Editorial: Tumour microenvironment in cancer research and d..:

Said, Nur Akmarina B. M. ; Mahmood, Syed ; To, Kenneth K. W.
Frontiers in Pharmacology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Circulating tumor cells shielded with extracellular vesicle..:

Yang, Chuan ; Wang, Xueping ; To, Kenneth K. W....
Signal Transduction and Targeted Therapy. 9 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

Utilizing non-coding RNA-mediated regulation of ATP binding..:

To, Kenneth K.W. ; Huang, Zoufang ; Zhang, Hang..
Drug Resistance Updates. 73 (2024) - p. 101058 , 2024

Link: https://doi.org/10.1016/..

5

A thermosensitive hydrogel formulation of phage and colisti..:

Mukhopadhyay, Subhankar ; To, Kenneth K. W. ; Liu, Yannan..
Biomaterials Science. 12 (2024) 1 - p. 151-163 , 2024

Link: https://doi.org/10.1039/..

6

Repurposing of triamterene as a histone deacetylase inhibit..:

To, Kenneth K. W. ; Cheung, Ka M. ; Cho, William C. S.
Journal of Cancer Research and Clinical Oncology. 149 (2023) 10 - p. 7217-7234 , 2023

Link: https://doi.org/10.1007/..

7

Drug Repurposing to Circumvent Immune Checkpoint Inhibitor ..:

To, Kenneth K. W. ; Cho, William C.
Pharmaceutics. 15 (2023) 8 - p. 2166 , 2023

Link: https://doi.org/10.3390/..

8

CD39/CD73/A2AR pathway and cancer immunotherapy:

Xia, Chenglai ; Yin, Shuanghong ; To, Kenneth K. W..
Molecular Cancer. 22 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

9

CM082 Enhances the Efficacy of Chemotherapeutic Drugs by In..:

Xu, Lejia ; Huang, Jiwei ; Liu, Jie...
Molecular Therapy - Oncolytics. 31 (2023) - p. 100746 , 2023

Link: https://doi.org/10.1016/..

10

Sequential treatment effects on phage–antibiotic synergisti..:

Mukhopadhyay, Subhankar ; Zhang, Pengfei ; To, Kenneth K.W....
International Journal of Antimicrobial Agents. 62 (2023) 5 - p. 106951 , 2023

Link: https://doi.org/10.1016/..

11

BET Bromodomain Inhibitors: Novel Design Strategies and The..:

To, Kenneth K. W. ; Xing, Enming ; Larue, Ross C..
Molecules. 28 (2023) 7 - p. 3043 , 2023

Link: https://doi.org/10.3390/..

12

Circumvention of Gefitinib Resistance by Repurposing Flunar..:

To, Kenneth K. W. ; Chow, James C. H. ; Cheung, Ka-Man.
ACS Pharmacology & Translational Science. 6 (2023) 10 - p. 1531-1543 , 2023

Link: https://doi.org/10.1021/..

13

Intercellular transfer of exosomal wild type EGFR triggers ..:

Wu, Shaocong ; Luo, Min ; To, Kenneth K. W....
Molecular Cancer. 20 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

14

Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current ..:

To, Kenneth K. W. ; Fong, Winnie ; Cho, William C. S.
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

15

WITHDRAWN: Pretomanid for the treatment of Mycobacterium tu..:

Fekadu, Ginenus ; To, Kenneth K.W. ; You, Joyce H.S.
Journal of Infection and Public Health. , 2021

Link: https://doi.org/10.1016/..